Plain-English translation of NCT05826054 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a new medication called Montbretin A designed to help control blood sugar spikes after meals in people with type 2 diabetes. Unlike common diabetes medications that can cause uncomfortable side effects like bloating and diarrhea, this treatment works by slowing down how quickly your body breaks down carbohydrates. The study will gradually increase the dose to find the right amount and check if it's safe and effective.
Current medications that prevent blood sugar spikes after eating often cause gas, bloating, and diarrhea, which makes many patients skip doses or stop taking them. This medication is being tested as a gentler alternative that might help people stick with their treatment and better manage their blood sugar.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic multiple times to take gradually increasing doses of the medication (starting at 10 mg and going up to 300 mg) with a standardized meal. At each visit, researchers will monitor you for side effects and only increase your dose if you tolerate it well. Blood samples will be taken to check how your body is responding, and you'll be asked to report any changes you notice.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Canada